Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_232_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
13.10.2026
Размер:
2 Мб
Скачать
☆
10. The High-Risk G
y
necolog
y
Patient: Assessment and Management 93
12. Talaat AS, Das N, Athavale R. Evaluation of P-POSSUM scorin
g
s
y
stem in patients
u
n
d
er
g
oin
g
gy
naeco
l
o
g
ica
l
onco
l
o
gy
sur
g
er
y
.
I
nt J G
y
naeco
l
Cancer. 2004;14(supp
l
)
:
7–
118
.
13. Gris
h
M, Trayner E, Dammann O, et a
l
. Symptom
l
imite
d
stair c
l
im
b
ing as a pre
d
ic
-
tor o
f
post-operative car
d
iopu
l
monary comp
l
ications a
f
ter
h
ig
h
ris
k
surgery. C
h
est.
2001;120
:
11
47–
11
5
1.
14. Reilly DF, Mcneely MJ, Doerner D, et al. Self reported exercise tolerance and the risk
o
f serious
p
erio
p
erative com
p
lications.
A
rch Intern Med
.
1999;1
5
9
:
218
5–
2192.
15. Older P, Hall A, Hader R. Cardiopulmonar
y
exercise testin
g
as a screenin
g
test
for perioperative mana
g
ement of ma
j
or sur
g
er
y
in the elderl
y
.
hest. 1999;11
6:
355
–
36
2
.
16. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative
morta
l
it
y
an
d
m
y
ocar
d
ia
l
in
f
arction in
h
i
gh
ris
k
patients un
d
er
g
oin
g
vascu
l
ar
sur
g
er
y
. Dutc
h
Ec
h
ocar
d
io
g
rap
h
ic Car
d
iac Ris
k
Eva
l
uation App
ly
in
g
Stress
E
c
h
ocar
d
iograp
h
y Stu
d
y Group.
N
Eng
l
J Me
d.
1999;3
4
1
:
1
7
89
–
1
7
9
4.
17. Devereaux PJ, Scott Beatie W, C
h
oi PTL, et a
l
. How strong is t
h
e evi
d
ence
f
or
t
h
e use o
f
p
erio
p
erative
-bl
oc
k
ers in non-car
d
iac surgery? Systematic review an
d
m
eta-analysis of randomised controlled trials. Br Med
J
. 2005
;
331:313–321.
18. Stuhmeier KD, Mainzer B, Cier
p
ka J, et al. Small oral dose of clonidine reduces the
incidence of intraoperative m
y
ocardial ischaemia in patients havin
g
vascular
sur
g
er
y
.
A
naesthesiolog
y
. 1996;85:706–712.
19. S
h
oema
k
er WC, Appe
l
PL, Kram HB, et a
l
. Prospective tria
l
o
f
supranorma
l
va
l
ues
of
survivors as t
h
erapeutic
g
oa
l
s in
h
i
gh
-ris
k
sur
g
ica
l
patients.
est
.
1988;94:1176–
118
6.
20. Wi
l
son J, Woo
d
s I, Fawcett J, et a
l
. Re
d
ucing t
h
e ris
k
o
f
major e
l
ective surgery:
ran
d
omise
d
contro
ll
e
d
tria
l
o
f
preoperative optimisation o
f
oxygen
d
e
l
ivery. Br Me
d
J.
1999;318
:
1099
–
1103
.
21. Alexander C, Liston W. Operating on the obese woman—a review.
B
r
J
Obste
t
Gynaecol. 200
6
;113:11
6
7–1172
.
22. Gan TJ, Horaek A, Maroof M, et al. Intraoperative volume expansion
g
uided b
y
esopha
g
eal doppler improved postoperative outcome and shortens hospital sta
y
.
Anesthesiolog
y.
2002;97:820–826
.
23. No
bl
ett SE, Snow
d
en CP, S
h
enton BK, et a
l
. Ran
d
omize
d
c
l
inica
l
tria
l
assessin
g
t
h
e
effect of doppler-optimised fl
uid management on outcome after elective colorectal
resection.
B
r J
S
urg. 200
6;
93:10
6
9–107
6.
24. Moraca RJ, S
h
e
ld
on DG, T
h
ir
lb
y RC. T
h
e ro
l
e o
f
epi
d
ura
l
anest
h
esia an
d
ana
l
gesia
in surgica
l
practise.
A
nn
S
urg. 2003
;
238:
66
3–
6
73
.
25. Pearse R, Dawson D, Fawcett J, et al. Early goal directed therapy after major surgery
reduces complications and duration of hospital stay. A randomised controlled trial.
Crit Care. 2005
;
9:
6
87–
6
93.
26. Cutillo G, Maneschi F, Franchi M, et al. Early feeding compared with nasogastric
d
ecompression after ma
j
or oncolo
g
ic
gy
naecolo
g
ic sur
g
er
y
: a randomised stud
y
.
Obstet G
y
naecol. 1999;93:41–45.
https://t.me/med1917
1. Complications in H
y
steroscopic
urger
y
: Prevention and
anagemen
t
Paul McGur
g
an
Peter
O
’Donova
n
ve years to learn when to operate and twenty years to learn when not
”
—Anon
y
mous
Th
ere is
l
itt
l
e
d
ou
b
t t
h
at minima
l
-access surgery (MAS) presents many a
d
van
-
t
ages over conventiona
l
surgery: sma
ll
er scars, re
d
uce
d
postoperative pain,
sh
orter
h
ospita
l
stay, an
d
spee
d
ier recovery.
W
it
h
any operation, t
h
ere may
b
e associate
d
comp
l
ications. T
h
ese may
b
e
divided into general risks, for example, anesthesia problems, and risks specifi
c
t
o t
h
e way t
h
e operation is per
f
orme
d
. MAS is no exception;
h
ysteroscopic
p
roce
d
ures invo
l
ve intro
d
uction o
f
instruments into t
h
e uterus, an
d
d
istension
w
it
h
me
d
ia in a
f
as
h
ion not use
d
conventiona
ll
y. As a resu
l
t, MAS
h
as a poten
-
t
ia
ll
y increase
d
ris
k
o
f
iatrogenic comp
l
ications, particu
l
ar
l
y
d
uring t
h
e
l
earn
-
i
ng p
h
ase o
f
t
h
e surgeon. T
h
is review
f
ocuses on practica
l
an
d
tec
h
no
l
ogica
l
ad
vances w
h
ere
b
y comp
l
ications may
b
e
d
ecrease
d
d
uring
h
ysteroscopic
s
u
r
ge
r
y.
The Sc
a
le
of
the Pr
ob
le
m
D
i
ff
erent proce
d
ures
h
ave
d
i
ff
erent comp
l
ication rates; an overview o
f
t
h
e
f
o
ll
owing
d
ata is presente
d
in Ta
bl
e 11.1, w
h
ic
h
gives t
h
e comp
l
ication an
d
e
mergency
h
ysterectomy rates reporte
d
f
or t
h
e MISTLETOE (Minima
ll
y Inva-
s
ive Surgica
l
Tec
h
niques—Laser, En
d
ot
h
erma
l
, or En
d
oresection) Stu
d
y [1]
.
C
omplications related to minimal-access procedures are relatively infre
-
q
uent. However, t
h
ere is
l
itt
l
e room
f
or comp
l
acency; rare comp
l
ications
f
or
a
n in
d
ivi
d
ua
l
surgeon can sti
ll
represent a major pro
bl
em on an internationa
l
s
ca
l
e.
Th
e
f
ormation o
f
nationa
l
supervisory
b
o
d
ies,
f
or examp
l
e, t
h
e Roya
l
C
o
ll
ege o
f
O
b
stetricians an
d
Gynaeco
l
ogists (RCOG) Wor
k
ing Party [2] an
d
th
e American Association o
f
Gyneco
l
ogic Laparoscopists (AAGL),
h
as pro
-
v
i
d
e
d
t
h
e impetus
f
or structure
d
training an
d
accre
d
itation.
https://t.me/med1917
11. Complications in H
y
steroscopic Surger
y
95
G
eneral Principles of Safe Hysteroscopic Surger
y
G
enera
l
princip
l
es o
f
sa
f
e
h
ysteroscopic surgery inc
l
u
d
e t
h
e
f
o
ll
owing:
Appropriate case se
l
ection
Pat
i
ent preparat
i
on
Proper equipment, inc
l
u
d
ing optima
l
exposure an
d
k
now
l
e
d
gea
bl
e
u
se o
f
e
l
ectrica
l
sources in e
l
ectrosurgery
Awareness o
f
t
h
e
l
earning p
h
ase
App
ro
p
riate Case Selection
P
roper case selection is one of the most important factors in reducin
g
complication rates for hysteroscopic surgery.
F
irst, one must accept that not all cases are suitable for h
y
steroscopic
s
ur
g
er
y
. There are uncertainties as to whether some patients are suitable for
MAS, e.
g
., h
y
steroscopic sur
g
er
y
for lar
g
e (
5 cm) type 2 submucous fi
b
r
o
i
ds
Table 11.2). While there ma
y
be claims b
y
a few specialists that it is feasible
t
o carry out these procedures hysteroscopically, it is important to appreciate
t
hat what ma
y
be achieved b
y
a small number of
g
ifted sur
g
eons ma
y
not be
r
eadil
y
achievable b
y
the avera
g
e practicin
g
g
eneral
gy
necolo
g
ist
.
P
roper case selection is of particular importance in the “learning phase”;
a
s a rule, start with simple cases. For example, when performin
g
h
y
steroscopic
resection of fi
broids, start with small type 0 or type 1 submucous fi
broids.
O
nce
experience and confi
dence have been gained, more diffi
cult cases may be
u
ndertaken. There is
g
ood evidence that complications are more likel
y
durin
g
hy
steroscopic m
y
omectom
y
and septum resections [3]
.
T
ab
le 11
.
1
.
Com
p
lications Associated with Endometrial Ablation or Resection
Technique Complication Rates (%) Emergenc
y
H
y
sterectom
y
Resection alone 10.9 13
/
1000
Rollerball alone 4.5 3
/
1000
Com
b
ine
d
resection
/
ro
ll
er
b
a
ll
7.7 5
/
1000
Laser 5.5 2
/
1000
Source: Ref. 1
.
T
a
bl
e 11.2. Classi
f
ication o
f
Submucous Leiomyoma
s
T
ype Locat
i
on
0
Pedunculate
d
<
5
0% intramura
l
2
>
5
0% intramura
l
https://t.me/med1917
9
6 P. McGur
g
an and P. O’Donovan
P
at
i
ent Preparat
i
on
App
ro
p
riate
p
atient
p
re
p
aration wi
ll
ma
k
e t
h
e o
p
eration easier an
d
re
d
uce
c
om
pl
ication rates
.
reoperat
i
ve Counsel
i
ng and Accurate Documentat
i
o
n
Th
e most important
f
actor in
d
ecreasin
g
l
iti
g
ation is a
f
u
lly
in
f
orme
d
p
atient, particu
l
ar
ly
i
f
t
h
ere are
k
nown ris
k
f
actors,
f
or examp
l
e, a
dh
esions, to
p
erformin
g
sur
g
er
y
. Patients ma
y
have unrealistic expectations about these
new procedures; a leafl
et explaining the procedure is a useful adjunct to a full
d
iscussion. A
p
lan should be made for a “worst-case scenario,” for instance,
t
he need for a laparotom
y
or h
y
sterectom
y
in the event of a uterine perfora-
t
ion. When complications do occur, the
y
should be full
y
documented, and
r
emedial sur
g
er
y
instituted as soon as possible [4].
ndometr
i
al Preparat
i
on
i
n Hysteroscop
i
c Surger
y
T
he need for endometrial
p
re
p
aration
p
rior to endometrial ablation is well
r
eco
g
nized. However, there is no consensus on endometrial preparation for
other hysteroscopic surgery, such as removal of septae or submucous fi
b
r
o
i
ds.
Th
e met
h
o
d
o
f
preparation varies,
b
ein
g
eit
h
er mec
h
anica
l
(curetta
g
e), or
p
harmacolo
g
ical (
g
onadotropin-releasin
g
hormone [GnRH], GnRH analo
g
s,
a
nd danazol). The Cochrane collaboration [5] found that GnRH analo
g
s are
a
ssociated with shorter duration of sur
g
er
y
,
g
reater ease of sur
g
er
y
, and hi
g
her
r
ate of postoperative amenorrhea at 12 months with h
y
steroscopic resection
or ablation. There also appears to be a benefi
cial effect on dysmenorrhea. The
u
se of GnRH analo
g
s has no effect on intraoperative complication rates, and
p
atient satisfaction with this sur
g
er
y
is hi
g
h, irrespective of the use of an
y
p
reoperative en
d
ometria
l
t
h
innin
g
a
g
ent. T
h
e
l
on
g
er-term e
ff
ects o
f
an
y
t
h
in-
n
in
g
a
g
ents are
l
ess certain,
b
ut w
h
ere reporte
d
, t
h
e e
ff
ect o
f
en
d
ometria
l
thinning agents on benefi
ts such as
p
osto
p
erative amenorrhea a
pp
ears to
r
educe with time
[
5
]
.
P
roper Equ
i
pment
I
t is essential to be properl
y
equipped before embarkin
g
on h
y
steroscopic
s
ur
g
er
y
. The minimum requirements should include a
g
ood-qualit
y
camera
s
ystem, light source, and image-recording facilities. However, it is more
i
mportant that both the surgeon and the theater staff be familiar with whatever
t
he available equipment is and how it operates
.
T
here are general precautions to follow to avoid complications arising
f
rom the use of electrical sources in hysteroscopic surgery [6]:
. Ensure good exposure. Activate the electric energy only when the tip
o
f the instrument is in contact with the target tissue and in the vie
w
o
f the hysteroscope, using the lowest possible power setting
.
https://t.me/med1917
11. Complications in H
y
steroscopic Surger
y
97
2
. Use
b
i
p
o
l
ar instruments w
h
enever
p
ossi
bl
e; t
h
is met
h
o
d
d
oes not
i
nvo
l
ve use o
f
a return p
l
ate, an
d
on
ly
a sma
ll
amount o
f
tissue is
i
nc
l
u
d
e
d
in t
h
e circuit, w
h
ic
h
means t
h
at
b
i
p
o
l
ar instruments can
u
sua
ll
y on
l
y
d
esiccate, an
d
capacitance cannot occur. Monopo
l
ar
systems require a return plate, and the current fl
ows through the
wh
o
l
e
b
o
dy
b
e
f
ore exitin
g
. A
l
t
h
ou
gh
monopo
l
ar instruments are
m
ore versati
l
e, capacitance an
d
d
irect coup
l
ing may occur i
f
precau-
t
ions are not ta
k
en [7]
.
3. Be aware o
f
t
h
e warnin
g
si
g
ns o
f
e
l
ectricit
y
l
ea
k
, suc
h
as invo
l
untar
y
c
ontraction o
f
t
h
e patient’s musc
l
es, or “
l
ig
h
tning” arti
f
acts on mon-
i
tors an
d
e
l
ectronic equipment. A re
d
uction in t
h
e expecte
d
e
l
ectro-
s
urgica
l
e
ff
ect at a given power setting an
d
energy mo
d
e may in
d
icate
th
at some o
f
t
h
e e
l
ectrica
l
energy
h
as
d
issipate
d
away
f
rom t
h
e tip
of
t
h
e active e
l
ectro
d
e. Do not
k
eep increasing t
h
e power output.
I
nstea
d
, c
h
ec
k
t
h
e app
l
ication o
f
t
h
e neutra
l
p
l
ate an
d
t
h
e insu
l
ation
of
t
h
e active e
l
ectro
d
e
.
Th
e easiest way to avoi
d
d
irect coup
l
ing is to activate energy on
l
y w
h
en
a
ll
o
f
t
h
e active part o
f
t
h
e instrument is visua
l
ize
d
, an
d
to ensure t
h
at part o
f
it is not in contact wit
h
any ot
h
er instrument. Direct coup
l
ing can a
l
so occur
d
ue to insu
l
ation
f
ai
l
ure, w
h
ic
h
may
b
e a
d
e
f
ect in t
h
e instrument’s insu
l
ation
invisible to the naked eye. This can be effectively confi
rmed only by electrical
tests on t
h
e instrument, an
d
emp
h
asizes t
h
e nee
d
f
or regu
l
ar inspection
b
y
testers to ensure t
h
e instrument’s integrity
.
Wh
i
l
e t
h
e intro
d
uction o
f
contact-qua
l
ity monitoring o
f
t
h
e return e
l
ec-
tro
d
e (Va
ll
ey
l
a
b
, Bou
ld
er, Co
l
o) e
ff
ective
l
y e
l
iminate
d
a
l
ternate-site
b
urns, t
h
e
intro
d
uction o
f
“active s
h
ie
ld
ing” o
f
t
h
e e
l
ectrosurgica
l
d
evices in t
h
e 1990s
(E
l
ectroscope, Bou
ld
er, Co
l
o) means t
h
at
d
evices using t
h
is tec
h
no
l
ogy are
extreme
l
y sa
f
e. T
h
ese
d
evices can
d
etect
d
irect coup
l
ing an
d
insu
l
ation
d
e
f
ects,
an
d
capture capacitive
l
y coup
l
e
d
energy. By e
l
imination, t
h
is
l
eaves t
h
e
s
urgeon so
l
e
l
y responsi
bl
e
f
or any a
d
verse e
ff
ects.
Th
e
h
ysteroscopic use o
f
e
l
ectrosurgery
h
as conventiona
ll
y
h
a
d
to use a
nonionic
d
istension me
d
ium
f
or o
b
vious reasons. G
l
ycine 1.5% an
d
sor
b
ito
l
3
% are common
l
y use
d
f
or operative
h
ysteroscopy. Consi
d
era
bl
e amounts o
f
t
h
ese non-iso-osmotic su
b
stances can
b
e a
b
sor
b
e
d
systemica
ll
y, wit
h
resu
l
tant
mor
b
i
d
ity an
d
morta
l
ity (Ta
bl
e 11.3). T
h
e use o
f
a
b
ipo
l
ar e
l
ectrosurgica
l
T
ab
le 11
.3.
AAGL Guidelines
f
or the Management
f
or Iatrogenic H
y
steroscopic Fluid
O
ver
load
De
f
icit Mana
g
ement
0.75 L Plan for completion of the case, as impendin
g
excessiv
e
i
ntr
a
v
a
s
a
t
io
n
1.5 L none
l
ectro
l
yte so
l
ution Conc
l
u
d
e case, assess e
l
ectro
l
ytes, consi
d
er
d
iuretic
a
d
ministration, an
d
initiate interventions as in
d
icate
d
2.5 L e
l
ectro
l
yte so
l
ution Conc
l
u
d
e case, assess e
l
ectro
l
ytes, consi
d
er
d
iuretic
a
d
ministration, an
d
initiate interventions as in
d
icate
d
Source: Ref. 16.
https://t.me/med1917
9
8 P. McGur
g
an and P. O’Donovan
d
evice (Versa
p
oint, Et
h
icon, Jo
h
nson & Jo
h
nson, New Brunswic
k
, NJ), w
h
ic
h
o
perates in an ionic sa
l
ine me
d
ium, represents a consi
d
era
bl
e
f
eat o
f
en
g
ineer
-
i
n
g
an
d
a va
l
ua
bl
e new instrument
f
or
hy
steroscopic sur
g
er
y
. T
h
e instrument’s
s
ma
ll
d
iameter means t
h
at operative proce
d
ures may
b
e per
f
orme
d
on con
-
s
c
i
ous pat
i
ents
i
n an outpat
i
ent sett
i
n
g.
A
wareness of the Learn
i
ng Phas
e
I
t is well reco
g
nized that complication rates are hi
g
her for cases performed
by
sur
g
eons durin
g
their learnin
g
phase. The followin
g
recommendations ma
y
h
el
p
to reduce com
p
lication rates
:
. One should be competent and experienced in doin
g
the procedure
v
ia laparotom
y
prior to embarkin
g
on an endoscopic approach
.
2
. T
h
ere are
d
i
ff
erent
l
eve
l
s o
f
comp
l
exit
y
in
hy
steroscopic sur
g
er
y
[2].
O
ne s
h
ou
ld
b
e
g
in wit
h
simp
l
e proce
d
ures an
d
not un
d
erta
k
e comp
l
e
x
p
rocedures until enou
g
h experience has been acquired. The compli
-
c
ation rates of advanced h
y
sterscopic sur
g
er
y
are 7 times those of
simpler h
y
steroscopic procedures [3]
.
3. In some cases, h
y
steroscopic sur
g
er
y
ma
y
be safer with concurrent
l
aparoscopic control, for example, resection of a t
y
pe 2 submucous
broid (especially if situated over the cornual region) and removal
of
uterine septum or
d
ense intrauterine a
dh
esions (As
h
erman’s s
y
n
-
d
rome). An experience
d
assistant wit
h
a secon
d
camera an
d
l
i
gh
t
source continuousl
y
monitors the amount of li
g
ht transmitted across
th
e uterine wa
ll
an
d
k
eeps t
h
e
b
owe
l
awa
y
f
rom t
h
e uterus. T
h
e
a
mount o
f
l
i
gh
t transmitte
d
s
h
ou
ld
b
e compare
d
wit
h
t
h
at via t
h
e
c
ornual re
g
ion—and should be no more than the latter. Combined
synchronous laparoscopic control should be considered in all diffi
c
ult h
y
steroscopic cases and durin
g
the learnin
g
curve of be
g
inners
8
].
4
. T
h
e RCOG
h
as out
l
ine
d
specia
l
s
k
i
ll
s mo
d
u
l
es in con
j
unction wit
h
th
e Britis
h
Societ
y
f
or G
y
naeco
l
o
g
ica
l
En
d
oscop
y
. T
h
ese specia
l
skills modules are desi
g
ned for trainees who have completed their
b
asic trainin
g
an
d
f
or esta
bl
is
h
e
d
consu
l
tants to conso
l
i
d
ate t
h
eir
s
k
i
ll
s. G
y
neco
l
o
g
ists s
h
ou
ld
contact preceptors in t
h
eir re
g
ion to
d
iscuss un
d
erta
k
in
g
trainin
g
.
C
ompl
i
cat
i
ons Spec
i
f
i
c to H
y
steroscop
y
A
s with any surgical procedure, there are potential complications due to
t
he mode of access as well as the actual sur
g
ical procedure performed. In this
section we confi
ne ourselves to the general principles of hysteroscopic surgery
w
ith emphasis on the accepted and newer methods of avoiding complications.
https://t.me/med1917
11. Complications in H
y
steroscopic Surger
y
9
9
Appropriate training in this new fi
eld is vital, with staged levels of procedures,
pro
g
ressin
g
on
ly
a
f
ter a
d
equate experience is
d
eve
l
ope
d
at eac
h
sta
g
e in
tra
i
n
i
n
g
.
Th
e 3 intrinsic comp
l
ications to an
y
hy
steroscopic proce
d
ure are
d
i
l
atin
g
t
h
e cervix, t
h
e use o
f
d
istension me
d
ia, an
d
t
h
e possi
b
i
l
it
y
o
f
uterine
p
erforation.
Di
lat
i
on and Perforat
i
on
Gy
necolo
g
ists are tau
g
ht to dilate the cervix from their earliest sur
g
ical
trainin
g
. However, patients for operative h
y
steroscop
y
will often have received
GnRH analo
g
s. While these dru
g
s are an important part of preoperative
endometrial preparation, they can have a signifi
ca
n
t
ste
n
ot
i
c
e
ff
ect
o
n
t
h
e
cervix. In the past, mana
g
ement options included traditional methods o
f
cervical dilation such as laminaria stents (Lamicel, Cabot Medical, Lan
g
horne,
Pa) or the more commonl
y
administered pharmacolo
g
ical methods, for
example, prosta
g
landins such as P
g
E2 or P
g
F2
α
. Increasin
g
l
y
, misoprostol
(Searle PLC, C
y
totec, Chica
g
o, Il) has been used as a method to prepare the
cervix prior to h
y
steroscopic sur
g
er
y
. A recent metaanal
y
sis has demonstrated
that the dru
g
is safe, and effective in reducin
g
cervical trauma and the need
for dilation
[
9
]
.
Th
e mana
g
ement o
f
per
f
oration
d
epen
d
s
l
ar
g
e
ly
on t
h
e instrument
b
ein
g
used. If a perforation occurs durin
g
uterine soundin
g
, a conservative approach
can be followed, b
y
stoppin
g
the procedure, treatment with antibiotics, and
overni
gh
t sta
y
. A
f
ter per
f
oration wit
h
a
l
ar
g
e
d
i
l
ator or an operative
hy
stero
-
s
cope, it is usua
lly
a
d
visa
bl
e to per
f
orm a
l
aparoscop
y
to eva
l
uate t
h
e extent
of trauma. Occasionall
y
it ma
y
be necessar
y
to perform a laparotom
y
, particu-
larl
y
if a perforation b
y
a “hot” instrument has occurred, or even a h
y
sterec-
tom
y
if bleedin
g
is heav
y
. The incidence of perforation durin
g
operative
proce
d
ures is experience
d
epen
d
ent an
d
is estimate
d
at 1%–2% o
f
ma
j
or
h
y
steroscopic cases [10]
.
Di
stens
i
on Med
i
a
G
as or liquid distension media are needed as a prerequisite for h
y
stero-
s
copic sur
g
er
y
, in order to keep the uterine walls separated and obtain a clear
view. It is the use of these media that creates complications specifi
c
to
h
y
steroscop
y.
T
he use of
CO
2
was fi
rst described by Rubin in 1925. Its advantages are
that it is cheap, easily available in operating theaters, nonfl
ammable, and rela
-
tivel
y
soluble in blood. It has a similar refractive index to air and allows
g
ood-
qualit
y
ima
g
es to be obtained. The disadvanta
g
es of CO
a
r
e
t
h
at
i
t
causes
bubbling in the presence of excess fl
uid or any bleeding; this effectively limits
https://t.me/med1917
00 P. McGur
g
an and P. O’Donovan
i
ts use to
d
ia
g
nostic
hy
steroscop
y
. I
f
intravasation occurs,
d
eat
h
s
h
ave
b
een
r
e
p
orte
d
d
ue to C
O
gas embolism. Therefore, fl
ow rates o
f
l
ess t
h
an 100 mL
/
min are fi
xed (a fl
ow rate of 30–40 mL/min is usually satisfactory).
Liquid distension media include high-viscosity fl
u
i
ds
suc
h
as
de
x
t
r
a
n
70
uids such as 5% dextrose, 1.5% glycine, 3% sor-
b
ito
l
, an
d
0.9% sa
l
ine. Di
ff
erent sur
g
eons
h
ave t
h
eir pre
f
erences: In t
h
e Unite
d
S
tates man
y
sur
g
eons pre
f
er H
y
s
k
on
b
ecause o
f
its immisci
b
i
l
it
y
wit
h
bl
oo
d
a
n
d
its
h
i
gh
viscosit
y
, w
h
ic
h
d
ecreases t
h
e ris
k
o
f
extravasation. However, t
h
e
high viscosity makes this medium diffi
cu
l
t
to
w
o
rk wi
t
h
a
n
d
n
ecess
i
tates
i
mmediate washin
g
of instruments in contact with it. Althou
g
h extravasation
is uncommon, a volume of only 300 mL is suffi
cient to cause pulmonary edema.
T
his is because dextran 70 is ver
y
h
y
drophilic and in the circulation it osmoti
-
c
all
y
shifts 6 times its own volume of water into the intravascular compart-
m
ent. The compound also has an effect on blood coa
g
ulation, rarel
y
causin
g
a
disseminated intravascular coa
g
ulation-t
y
pe consumptive coa
g
ulopath
y
,
a
nd has been linked to adult respirator
y
distress s
y
ndrome [11].
Low-viscosity fl
uids are more commonly used in the United Kingdom;
a
lthou
g
h the
y
are miscible with blood, the
y
are not associated with an
y
coa
g
u-
l
opat
h
ic or a
ll
er
g
ic comp
l
ications. Dextrose 5% is rare
ly
use
d
; it
h
as no a
d
van
-
t
a
g
e over saline and has the side effect of bein
g
h
y
po-osmolar. The solutions
m
ainl
y
used for operative h
y
steroscop
y
are 1.5%
g
l
y
cine and 3% sorbitol. Both
o
f these are nonionic and therefore suitable for electrosur
g
er
y
. Gl
y
cine, which
w
as used ori
g
inall
y
b
y
urolo
g
ists, is h
y
po-osmolar, and excess absorption
r
esults in a dilutional h
y
ponatemia, which can be further complicated b
y
a
s
ubsequent h
y
perammonemia, which results from
g
l
y
cine’s intrahepatic
m
etabolism, causin
g
the TURP s
y
ndrome. With all these compounds, vi
g
i-
l
ance is man
d
ator
y
, an
d
d
eat
h
s
h
ave
b
een reporte
d
. Sor
b
ito
l
is simi
l
ar to
gly
cine,
b
ein
g
hy
po-osmo
l
ar (approx. 170 mOsm); it a
l
so
h
as meta
b
o
l
ic com-
p
lications, causin
g
h
y
per
g
l
y
cemia due to its breakdown. Mannitol is a rela
-
t
ivel
y
new medium bein
g
used [12]. Its advanta
g
e is that it is iso-osmolar
a
pp
rox. 285 mOsm), and it is a natural osmotic diuretic. Little ex
p
erience of
a
n
y
comp
l
ications
h
as
b
een
d
ocumente
d
in t
h
e
l
iterature to
d
ate;
h
owever,
m
annitol will cause a volume overload if lar
g
e intravasation occurs.
U
ntil recentl
y
, operative h
y
steroscopic sur
g
er
y
was limited to requirin
g
a
n
onionic me
d
ium, as e
l
ectrosur
g
er
y
in an ionic environment cou
ld
not
b
e
p
er
f
orme
d
; t
h
e current wou
ld
simp
ly
d
isperse t
h
rou
gh
out t
h
e me
d
ium.
H
owever, Versapoint can operate in an ionic saline medium (Fi
g
ures 11.1 and
1.2), w
h
ic
h
represents a consi
d
era
bl
e
f
eat o
f
en
g
ineerin
g
. T
h
e instrument
h
as
b
ecome a va
l
ua
bl
e
d
evice in
hy
steroscopic sur
g
er
y
; t
h
e sma
ll
-
d
iameter (5
F
rench) means that operative procedures ma
y
also be performed on conscious
p
atients in an outpatient settin
g
. Our experience [14] a
g
rees wit
h
t
h
e ver
y
positive initial reports. However, care must still be taken to avoid fl
u
i
d
o
v
e
r-
load, although the osmotically induced fl
u
i
d
s
hif
ts
c
h
a
r
acte
ri
st
i
c
o
f
ot
h
e
r
med
i
a
a
r
e
minimiz
ed.
I
t is essential that all operatin
g
theaters performin
g
h
y
steroscopic sur
g
er
y
have a system for monitoring fl
uid defi
cits during the procedure and a proto-
col for the management of excessive defi
cits
(
Table 11.3
)
[15,16]. Prevention
i
s better than cure, and there are man
y
devices that attempt to calculate the
https://t.me/med1917
11. Complications in H
y
steroscopic Surger
y
101
Fi
g
ure 11.1. Versapoint (Ethicon, Johnson & Johnson, New Brunswick, NJ) “smart”
g
enera-
tor, which automaticall
y
controls power output to the tissue impedance
.
amount of fl
uid absorbed during the procedure. These range in sophistication
from syringes, to calibrated fl
uid bags hung at a certain height over the level
of the uterus (60–100 cm) with a collectin
g
bucket or pouch in the subperineal
drapes, to calibrated spring-weight gauges. If any of these simpler devices are
used, the fl
uid balance must be checked every 5 minutes.
A
b
i
oc
h
e
mi
ca
l m
et
h
od
used
f
o
r
t
h
e
assess
m
e
n
t
o
f
abso
r
bed
fl
u
i
d
i
s
t
h
e
addition of a small
(
1%–2%
)
amount of ethanol to the distension media; this
measures the s
y
stemic fl uid absorption b
y
anal
y
zin
g
the alcohol expired b
y
the patient. There is ver
y
little literature on this area, bein
g
mostl
y
small trials
[14], and the potential complications of s
y
stemic alcohol in a postoperative
p
atient are cause for concern
.
T
here are a wide variety of pump systems, ranging from simple pumps,
w
h
ere a constant rate o
f
fl
ow o
f
fl
ui
d
is pro
d
uce
d
at a given pump rate, to
s
op
h
isticate
d
pressure-contro
ll
e
d
pump systems. Our experience is wit
h
th
e pressure-
l
imite
d
rotary pump system (t
h
is avoi
d
s t
h
e catastrop
h
ic com-
pl
ications
d
ue to t
h
e gas-
d
riven variety), t
h
e Hamou En
d
omat (Kar
l
Storz,
Tuttlingen, Germany). Our experience agrees with Hamou’s fi
ndings [17]
https://t.me/med1917
02 P. McGur
g
an and P. O’Donovan
of
d
ecrease
d
fl
ui
d
a
b
sorption an
d
d
ecrease
d
mor
b
i
d
ity. At present t
h
ere is
n
o consensus on
hy
steroscopic monitorin
g
;
h
owever, in France,
g
overnment
l
egis
l
ation
f
or
b
i
d
s
h
ysteroscopic surgery un
l
ess a pump system is
b
eing
u
se
d
.
B
leedin
g
Th
e preva
l
ence o
f
h
emorr
h
age
d
epen
d
s on t
h
e
f
orm o
f
energy use
d
f
or
a
blation. With loop and rollerball or loop alone, the incidence of hemorrhage
i
s 2.57% an
d
3.53%, respective
l
y, w
h
ereas wit
h
l
aser or ro
ll
er
b
a
ll
it is 1.17%
a
nd 0.97%, respectively [1]. The new “second-generation” endometrial abla-
t
ion devices usually have no risk of causing uterine bleeding as a result of their
e
ndometrial destructive rather than resective designs
.
I
ntrauterine
bl
ee
d
ing occurring
d
uring t
h
e proce
d
ure s
h
ou
ld
b
e imme
d
i-
a
te
l
y o
b
vious an
d
can usua
ll
y
b
e contro
ll
e
d
b
y spot e
l
ectrocoagu
l
ation. I
f
c
oagu
l
ation
f
ai
l
s to contro
l
t
h
e
bl
ee
d
ing, t
h
e proce
d
ure may
h
ave to
b
e a
b
an-
d
one
d
an
d
tampona
d
e per
f
orme
d
b
y inserting a Fo
l
ey cat
h
eter an
d
d
isten
d
ing
th
e
b
a
ll
oon. T
h
e cat
h
eter s
h
ou
ld
b
e
l
e
f
t in situ
f
or a
f
ew
h
ours, a
f
ter w
h
ic
h
t
h
e
bl
ee
d
ing near
l
y a
l
ways stops
.
S
alin
e
nv
i
r
o
nmen
t
Vap
or
o
ket
ke
Con
C
tro
tro
lle
lle
d
d
d
TheThe
Th
T
T
rma
l
ect
ect
Tis
sue
u
Cu
Cur
Cur
Cu
Cu
u
ren
ren
r
t
w
w
Act
ive
ive
ctr
ct
c
c
ode
i
g
ure 11.2
.
Versa
p
oint (Ethicon, Johnson & Johnson, New Brunswick, NJ) bi
p
olar electro
-
s
urger
y
in an ionic environment.
https://t.me/med1917